Search

Your search keyword '"Stevens, Alexandra"' showing total 230 results

Search Constraints

Start Over You searched for: Author "Stevens, Alexandra" Remove constraint Author: "Stevens, Alexandra" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
230 results on '"Stevens, Alexandra"'

Search Results

9. Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children’s Hospital at Baylor College of Medicine

11. Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation

19. Organizational Capacity Building for Sexual Health Promotion

20. Tibial Spine Fractures in the Child and Adolescent Athlete: A Systematic Review and Meta-analysis.

21. Poster 246: Epidemiology of Tibial Spine Fractures in Children: A National Multicenter Study

29. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience

30. Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated

31. BCM PDX Portal: An Intuitive Web-based Tool for Patient-Derived Xenograft Collection Management, as well as Visual Integration of Clinical and Omics Data

33. A Novel Oncodental Collaborative Team: Integrating Expertise for Central Line–Associated Bloodstream Infection Prevention in Pediatric Oncology Patients

34. Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML

36. Phase I Study of Tagraxofusp with or without Chemotherapy in Pediatric Patients with Relapsed or Refractory CD123-Expressing Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium Trial

37. Development of a Pediatric AML Patient Derived Xenograft Program

41. Chlorhexidine gluconate (CHG) foam improves adherence, satisfaction, and maintains central line associated infection rates compared to CHG wipes in pediatric hematology-oncology and bone marrow transplant patients

42. Real‐world experience in treating pediatric relapsed/refractory or therapy‐related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium

45. IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group report.

46. Chlorhexidine gluconate (CHG) foam improves adherence, satisfaction, and maintains central line associated infection rates compared to CHG wipes in pediatric hematology-oncology and bone marrow transplant patients.

49. Ex Vivo Drug Sensitivity Assay Correlates with Clinical Response and Identifies Panobinostat and Bortezomib As a Potential Novel Drug Combination for Pediatric AML

50. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Collaboration

Catalog

Books, media, physical & digital resources